Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

48 results for Pharmaceuticals
CLEAR ALL
Actylis
Solvent, buffering agent and pH modifier designed for injectable formulations. This excipient is also used as a co-solvent in pharmaceutical preparations. Benefits:
  • Highly pure syrupy liquid
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with USP, Ph. Eur and BP specification
Actylis
Solvent, buffering agent and pH modifier suitable for injectable formulations. This excipient also acts as a co-solvent in pharmaceutical preparations.Benefits:
  • Highly pure syrupy liquid
  • Complies with USP, Ph. Eur and BP specification
  • Helps to maintain low level of endotoxins and metallic impurities
Actylis
Excipient developed for pharmaceutical preparations. It is used as a buffering agent and pH modifier in injectable formulations. Benefits:
  • Colorless syrupy liquid
  • Helps to maintain low level of endotoxins and metallic impurities
  • Complies with USP, Ph. Eur and BP specifications
Actylis
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
  • DMF Filed
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/ Co-solvent and chelating agent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Solvent, co-solvent and chelating agent designed for injectable formulations. Benefits:
  • Helps to maintain low level of endotoxins and metallic impurities
  • Compliant with USP and Ph. Eur
Actylis
Preservative and antimicrobial excipient for injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
Actylis
Excipients for injectable formulations. It is recommended for pharmaceutical applications.Benefits:
  • Acts as buffering agents/pH modifiers
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Preservative and antimicrobial excipient used in injectable formulations.Benefits:
  • Controlled metallic impurities
  • Maintains low level of endotoxins with the bioburden limits- BET/MLT
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Excipient developed for injectable formulations. It functions as a preservative/antimicrobial. Benefits:
  • Maintains a low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Antioxidant and reducing agent used in injectable formulations. t is an excipient designed for solid and semi-solid dosage forms. Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:
  • DMF Filed - CDE # F20200000189
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Dc Pharma
Oxytetracycline hydrochloride designed for pharmaceutical applications. It is suitable for injections. Shelf life: 3 years.Benefits:
  • Meets with EP 10 specifications
CEP available